Related Experiment Videos
Myocardial infarction in diabetics
Insights
Hospital mortality for acute myocardial infarction (AMI) in diabetics remains high, with 51% mortality at 12 months. Coronary care unit treatment improved outcomes for those on oral medications but not insulin.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Acute myocardial infarction (AMI) poses a significant risk to patients with diabetes mellitus.
- Understanding mortality patterns in diabetic patients post-AMI is crucial for improving clinical outcomes.
Purpose of the Study:
- To analyze hospital mortality rates and influencing factors for diabetic patients experiencing AMI.
- To evaluate the impact of coronary care unit (CCU) treatment on mortality in this population.
Main Methods:
- Retrospective analysis of 285 diabetic patients diagnosed with AMI over a decade.
- Comparison of mortality rates based on diabetes management (insulin vs. oral hypoglycaemic drugs), gender, age, diabetes duration, and retinopathy presence.
- Assessment of CCU treatment effectiveness.
Main Results:
- Overall 12-month hospital mortality for AMI in diabetics was 51%.
- CCU treatment benefited patients on oral hypoglycaemic drugs but not those on insulin.
- Female patients on oral hypoglycaemic drugs exhibited the highest mortality.
- Diabetics on oral therapy showed worse outcomes compared to insulin-treated patients when considering age, diabetes duration, and retinopathy.
Conclusions:
- AMI in diabetic patients has a high mortality rate, with limited improvement over 12 months.
- Diabetes management strategy (insulin vs. oral agents) significantly impacts AMI outcomes.
- Targeted interventions for high-risk subgroups, such as females on oral hypoglycaemic drugs, are warranted.
Abstract:
The hospital mortality of acute myocardial infarction amongst 285 known diabetics treated in the last decade was 39.7 per cent at one month and had increased to 51 per cent at 12 months. Treatment in a coronary care unit during the acute stage had little effect on the mortality amongst patients on insulin, but was beneficial for patients whose diabetes had been controlled by oral hypoglycaemic drugs. Female patients on oral hypoglycaemic drugs had the highest mortality. When considering age, duration of diabetes and presence of retinopathy, acute myocardial infarction in diabetics controlled on oral therapy appeared to have a worse outcome than in patients on insulin. Independently of whether patients were on insulin or on oral hypoglycaemic drugs 12 months after the acute episode, only about half of them were still alive.